Back

Impact of nebivolol versus carvedilol on long-term clinical outcomes in STEMI patients treated with drug-eluting stents

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

6 More presentations in this session

Presentation thumbnail
Discussant - Expanding pharmacological and non-pharmacological options for coronary disease
Presentation thumbnail
The effectiveness of allopurinol in improving ischemic symptoms or exercise tolerance in patients with chronic coronary syndromes: a systematic review and meta-analysis of randomized clinical trials
Doctor S. Del Vecchio Ziotti (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Baseline characteristics, treatment and mortality among acute myocardial infarction patients with varying left ventricular ejection fractions according to the Estonian Myocardial Infarction Registry
Doctor J. Smirnova (Tartu, EE)
Abstract
Presentation thumbnail
Preliminary experience with comprehensive treatment in patients with rapidly progressive coronary artery disease (RP-CAD)
Doctor Y. Liu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Intensified hypolipidaemic therapy with inclisiran for atherosclerotic plaque stabilization
Doctor B. Kokina (Riga, LV)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources